Sort by
Search results
CoaChrom™ Moderate Abnormal Control Plasma
Moderate Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
CoaChrom™ Moderate and Severe Abnormal Control Plasma
CoaChrom™ Severe Abnormal Control Plasma
Severe Abnormal Control Plasma for the quality control of FVIII, FIX and vWF assays. For Research Use Only.
Collagen
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Contact
What can we do for you? Here you will find our contact details and a contact form. We are at your disposal for all your concerns.
Corn Trypsin Inhibitor (CTI)
FXIIa inhibitor.
DOAC-Remove™20
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™250
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™50
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOACs (Direct oral Anticoagulants)